Export 26 results:
Author [ Title(Desc)] Type Year
Filters: Author is Srivastava, Alok  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Daniel HD-J, Kumar S, Kannangai R, J F, Joel JN, Abraham A, Lakshmi KM, Agbandje-McKenna M, Coleman KE, Srivastava A, Srivastava A, Abraham AM.  2022.  Age-stratified adeno-associated virus serotype 3 neutralizing and total antibody prevalence in hemophilia A patients from India.. J Med Virol. 94(9):4542-4547. DOI:10.1002/jmv.27859.
B
Rajendiran V, Devaraju N, Haddad M, Ravi NSam, Panigrahi L, Paul J, Gopalakrishnan C, Wyman S, Ariudainambi K, Mahalingam G, Periyasami Y, Prasad K, George A, Sukumaran D, Gopinathan S, Pai AAnand, Nakamura Y, Balasubramanian P, Ramalingam R, Thangavel S et al..  2024.  Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression.. Mol Ther. 32(3):663-677. DOI:10.1016/j.ymthe.2024.01.023.
C
Karuppusamy KV, Demosthenes JPaul, Venkatesan V, Christopher ACrystal, Babu P, Azhagiri MK, Jacob A, Ramalingam VVadhini, Rangaraj S, Murugesan MKumarasamy, Marepally SKumar, Varghese GM, Srivastava A, Kannangai R, Thangavel S.  2022.  The CCR5 Gene Edited CD34(+)CD90(+) Hematopoietic Stem Cell Population Serves as an Optimal Graft Source for HIV Gene Therapy.. Front Immunol. 13:792684. DOI:10.3389/fimmu.2022.792684.
Hwang WYk, Takahashi S, Choi B, Huang H, Kawamata S, Ng SChin, Gupta P, Hamidieh AAli, Koaykul C, Irawan C, Srivastava A.  2024.  Challenges in Global Access to CAR-T cells: an Asian Perspective.. Blood Cell Ther. 7(1):10-13. DOI:10.31547/bct-2023-023.
Kumar SRP, Xie J, Hu S, Ko J, Huang Q, Brown HC, Srivastava A, Markusic DM, Doering CB, H Spencer T, Srivastava A, Gao G, Herzog RW.  2021.  Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette.. Mol Ther Methods Clin Dev. 23:98-107. DOI:10.1016/j.omtm.2021.08.001.
Kachroo U, Zachariah SMary, Thambaiah A, Tabasum A, Livingston A, Rebekah G, Srivastava A, Vinod E.  2021.  Comparison of Human Platelet Lysate versus Fetal Bovine Serum for Expansion of Human Articular Cartilage-Derived Chondroprogenitors.. Cartilage. 13(2_suppl):107S-116S. DOI:10.1177/1947603520918635.
Mahalingam G, Arjunan P, Periyasami Y, Dhyani AKumar, Devaraju N, Rajendiran V, Christopher ACrystal, Kt RDevi, Dhanasingh I, Thangavel S, Murugesan M, Moorthy M, Srivastava A, Marepally S.  2023.  Correlating the differences in the receptor binding domain of SARS-CoV-2 spike variants on their interactions with human ACE2 receptor.. Sci Rep. 13(1):8743. DOI:10.1038/s41598-023-35070-2.
D
Srivastava A.  2024.  Defining success in haemophilia care - Are we doing it right? Haemophilia. 30 Suppl 3:52-59. DOI:10.1111/hae.14958.
Singh G, Manian KV, Premkumar C, Srivastava A, Daniel D, Velayudhan SR.  2022.  Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions.. Methods Mol Biol. 2454:775-789. DOI:10.1007/7651_2021_349.
Baldia M, Mani S, Walter N, Kumar S, Srivastava A, Prabhu K.  2021.  Development of a Unique Mouse Intervertebral Disc Degeneration Model Using a Simple Novel Tool.. Asian Spine J. 15(4):415-423. DOI:10.31616/asj.2020.0366.
Bagchi A, Nath A, Thamodaran V, Ijee S, Palani D, Rajendiran V, Venkatesan V, Datari P, Pai AAnand, Janet NBeryl, Balasubramanian P, Nakamura Y, Srivastava A, Mohankumar KMurugesan, Thangavel S, Velayudhan SR.  2021.  Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells.. Cells. 10(3) DOI:10.3390/cells10030523.
E
Venkatesan V, Christopher ACrystal, Rhiel M, Azhagiri MKumar K, Babu P, Walavalkar K, Saravanan B, Andrieux G, Rangaraj S, Srinivasan S, Karuppusamy KV, Jacob A, Bagchi A, Pai AAnand, Nakamura Y, Kurita R, Balasubramanian P, Pai R, Marepally SKumar, Mohankumar KMurugesan et al..  2023.  Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.. Mol Ther Nucleic Acids. 32:671-688. DOI:10.1016/j.omtn.2023.04.024.
Young G, Srivastava A, Kavakli K, Ross C, Sathar J, You C-W, Tran H, Sun J, Wu R, Poloskey S, Qiu Z, Kichou S, Andersson S, Mei B, Rangarajan S.  2023.  Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial.. Lancet. 401(10386):1427-1437. DOI:10.1016/S0140-6736(23)00284-2.
George A, Ravi NSam, Prasad K, Panigrahi L, Koikkara S, Rajendiran V, Devaraju N, Paul J, Pai AAnand, Nakamura Y, Kurita R, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR, Srivastava A, Mohankumar KM.  2022.  Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2.. Front Genome Ed. 4:1085111. DOI:10.3389/fgeed.2022.1085111.
Bagchi A, Devaraju N, Chambayil K, Rajendiran V, Venkatesan V, Sayed N, Pai AAnand, Nath A, David E, Nakamura Y, Balasubramanian P, Srivastava A, Thangavel S, Mohankumar KM, Velayudhan SR.  2022.  Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applications.. Sci Rep. 12(1):14033. DOI:10.1038/s41598-022-13783-0.
F
Srivastava A, Rangarajan S, Kavakli K, Klamroth R, Kenet G, Khoo L, You C-W, Xu W, Malan N, Frenzel L, Bagot CN, Stasyshyn O, Chang C-Y, Poloskey S, Qiu Z, Andersson S, Mei B, Pipe SW.  2023.  Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial.. Lancet Haematol. 10(5):e322-e332. DOI:10.1016/S2352-3026(23)00037-6.
H
Reiss UM, Mahlangu J, Ohmori T, Ozelo MC, Srivastava A, Zhang L.  2022.  Haemophilia gene therapy-Update on new country initiatives.. Haemophilia. 28 Suppl 4:61-67. DOI:10.1111/hae.14512.
H van den Berg M, Srivastava A.  2023.  Hemostasis - A Balancing Act.. N Engl J Med. 389(9):853-856. DOI:10.1056/NEJMe2304535.
I
Ravi NSam, Wienert B, Wyman SK, Bell HWilliam, George A, Mahalingam G, Vu JT, Prasad K, Bandlamudi BPrasad, Devaraju N, Rajendiran V, Syedbasha N, Pai AAnand, Nakamura Y, Kurita R, Narayanasamy M, Balasubramanian P, Thangavel S, Marepally S, Velayudhan SR et al..  2022.  Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.. Elife. 11 DOI:10.7554/eLife.65421.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL.  2023.  International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.. Cytotherapy. 25(9):920-929. DOI:10.1016/j.jcyt.2023.03.002.
M
Balakrishnan B, Illangeswaran RStephen St, Rajamani BMurugan, Arunachalam AKumar, Pai AAnand, Mohanan E, Srivastava A, Mathews V, Balasubramanian P.  2023.  Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.. PLoS One. 18(10):e0293311. DOI:10.1371/journal.pone.0293311.
O
Mahalingam G, Periyasami Y, Arjunan P, Subaschandrabose RKumar, Mathivanan TVenthan, Mathew RSusan, Devi KRamya, Premkumar PSamuel, Muliyil J, Srivastava A, Moorthy M, Marepally S.  2022.  Omicron infection increases IgG binding to spike protein of predecessor variants.. J Med Virol. DOI:10.1002/jmv.28419.
Mahalingam G, Rachamalla HKrishnared, Arjunan P, Periyasami Y, M S, Thangavel S, Mohankumar KM, Moorthy M, Velayudhan SR, Srivastava A, Marepally S.  2022.  Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System.. Front Pharmacol. 13:840727. DOI:10.3389/fphar.2022.840727.
P
Cuende N, Ciccocioppo R, Forte M, Galipeau J, Ikonomou L, Levine BL, Srivastava A, Zettler PJ.  2022.  Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products.. Cytotherapy. 24(7):686-690. DOI:10.1016/j.jcyt.2022.03.007.
Christopher ACrystal, Venkatesan V, Karuppusamy KV, Srinivasan S, Babu P, Azhagiri MKumar K, Chambayil K, Bagchi A, Rajendiran V, Ravi NSam, Kumar S, Marepally SKumar, Mohankumar KMurugesan, Srivastava A, Velayudhan SR, Thangavel S.  2022.  Preferential Expansion of Human CD34CD133CD90 Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy.. Hum Gene Ther. 33(3-4):188-201. DOI:10.1089/hum.2021.089.
S
Mahalingam G, Rachamalla HKrishnared, Arjunan P, Karuppusamy KV, Periyasami Y, Mohan A, Subramaniyam K, M S, Rajendran V, Moorthy M, Varghese GM, Mohankumar KM, Thangavel S, Srivastava A, Marepally S.  2024.  SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants.. Mol Ther. DOI:10.1016/j.ymthe.2024.02.028.